SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib
30 Oct 2023 //
EXPRESS PHARMA
Sun Pharma inks licensing pact with SPARC to commercialise medication in US
10 Nov 2022 //
ECONOMIC TIMES
SPARC licenses rights of PDP-716 and SDN-037 to Visiox Pharma
07 Dec 2021 //
EXPRESS PHARMA